APC mutations in sporadic medulloblastomas.

The cerebellar medulloblastoma (WHO Grade IV) is a highly malignant, invasive embryonal tumor with preferential manifestation in children. Several molecular alterations appear to be involved, including isochromosome 17q and the p53, PTCH, and beta-catenin gene mutations. In this study, 46 sporadic medulloblastomas were screened for the presence of mutations in genes of the Wnt signaling pathway (APC and beta-catenin). Single-strand conformational polymorphism (SSCP) analysis followed by direct DNA sequencing revealed 3 miscoding APC mutations in 2 (4.3%) medulloblastomas. One case contained a GCA-->GTA mutation at codon 1296 (Ala-->Val), and another case had double point mutations at codons 1472 (GTA-->ATA, Val-->Ile) and 1495 (AGT-->GGT, Ser-->Gly). Miscoding beta-catenin mutations were detected in 4 tumors (8.7%). Three of these were located at codon 33 (TCT -->TTT, Ser-->Phe) and another at codon 37 (TCT-->GCT, Ser-->Ala). Adenomatous polyposis coli (APC) gene and beta-catenin mutations were mutually exclusive and occurred in a total of 6 of 46 cases (13%). Although germline APC mutations are a well established cause of familial colon and brain tumors (Turcot syndrome), this study provides the first evidence that APC mutations are also operative in a subset of sporadic medulloblastomas.

[1]  S Ichii,et al.  The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. , 1992, Cancer research.

[2]  K. Kinzler,et al.  The molecular basis of Turcot's syndrome. , 1995, The New England journal of medicine.

[3]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[4]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[5]  A. Vortmeyer,et al.  Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome‐associated medulloblastoma , 1999, Cancer.

[6]  L. Rorke,et al.  Chromosome abnormalities in pediatric brain tumors. , 1988, Cancer research.

[7]  Y. Nakamura,et al.  Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. , 1992, Human molecular genetics.

[8]  Erwin G. Van Meir,et al.  Brain tumor-polyposis syndrome: two genetic diseases? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[10]  P. Kleihues,et al.  p53 mutations in nonastrocytic human brain tumors. , 1991, Cancer research.

[11]  W. Cavenee,et al.  p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma. , 1994, Cancer research.

[12]  S. Hirohashi.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. , 1998, The American journal of pathology.

[13]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[14]  M. Wolter,et al.  Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. , 1997, Cancer research.

[15]  Paul Polakis,et al.  The oncogenic activation of β-catenin , 1999 .

[16]  T. Sekiya,et al.  Mutations of the adenomatous polyposis coli gene in the mutation cluster region: Comparison of human pancreatic and colorectal cancers , 1994, International journal of cancer.

[17]  R. White.  Excess risk of colon cancer associated with a polymorphism of the APC gene? , 1998, Cancer research.

[18]  W. Nelson,et al.  Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. , 1997, Current opinion in cell biology.

[19]  A. Scarpa,et al.  APC gene mutations and allelic losses in sporadic ampullary tumours: Evidence of genetic difference from tumours associated with familial adenomatous polyposis , 1996, International journal of cancer.

[20]  P. Polakis,et al.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Kinzler,et al.  Association between wild type and mutant APC gene products. , 1993, Cancer research.

[22]  Yusuke Nakamura,et al.  Germ‐line and somatic mutations of the APC gene in patients with turcot syndrome and analysis of APC mutations in brain tumors , 1994, Genes, chromosomes & cancer.

[23]  S. Hirohashi,et al.  Beta-catenin mutation in carcinoma of the uterine endometrium. , 1998, Cancer research.

[24]  S Ichii,et al.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. , 1992, Human molecular genetics.

[25]  M. Buendia,et al.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Ishikawa,et al.  Somatic mutations of the APC gene in sporadic hepatoblastomas. , 1996, Cancer research.

[27]  A. von Deimling,et al.  The APC gene in Turcot's syndrome. , 1995, The New England journal of medicine.

[28]  C. James,et al.  Sporadic medulloblastomas contain PTCH mutations. , 1997, Cancer research.

[29]  P. Polakis.  Mutations in the APC gene and their implications for protein structure and function. , 1995, Current opinion in genetics & development.

[30]  Thierry Soussi,et al.  APC gene: database of germline and somatic mutations in human tumors and cell lines , 1996, Nucleic Acids Res..

[31]  Webster K. Cavenee,et al.  Pathology and genetics of tumours of the nervous system. , 2000 .

[32]  K. Kinzler,et al.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Raffel,et al.  Sporadic Medulloblastomas Contain Oncogenic β-Catenin Mutations , 1998 .

[34]  Bert Vogelstein,et al.  Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .

[35]  T Pietsch,et al.  Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. , 1997, Cancer research.

[36]  E. Gelmann,et al.  β-Catenin Mutations in Human Prostate Cancer , 1998 .

[37]  D. Bigner,et al.  Structural chromosomal abnormalities in human medulloblastoma. , 1988, Cancer genetics and cytogenetics.

[38]  S. Baylin,et al.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 , 1995, Nature Genetics.